3 days Travere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates Zacks

Travere (TVTX) delivered earnings and revenue surprises of -25.86% and 1.84%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?